-
2023-506723-28-00
4
2025-03-20
Mitochondrial encephalomyopathy, lactic acidosis and stroke-like episo
-
2024-511440-76-00
1
2025-03-20
Cutaneous Squamous Cell Carcinoma
-
2024-516493-30-01
4
2025-03-10
stress
anxiety
-
2024-516055-41-00
6
2025-03-06
None
-
2024-513125-23-00
4
2025-02-28
Patients with moderate to high risk for cardiac surgery associated- ac
-
2024-518122-33-00
6
2024-12-13
Peripheral Arterial Disease
-
2024-512278-92-00
4
2024-12-09
Pulmonary Arterial Hypertension (PAH)
-
2022-502367-37-00
7
2024-11-29
Recurrent glioblastoma multiforme (GBM)
-
2024-515263-60-00
6
2024-11-22
SARS-CoV-2 infection
-
2024-510816-55-00
4
2024-11-08
Candidemia
-
2024-516260-29-00
5
2024-10-10
non-metastatic (borderline) resectable pancreatic cancer
-
2023-510232-36-00
3
2024-10-01
healthy breastfeeding women
-
2022-502095-23-01
10
2024-09-10
Primary Immunodeficiency Diseases
-
2024-514311-10-00
5
2024-08-10
Cluster headache
-
2024-513124-41-00
5
2024-07-12
Primary antibody deficiency:
- Unclassified antibody deficiency (unPAD
-
2023-506425-12-00
5
2024-04-17
Uncontrolled and Resistant Hypertension
-
2023-505022-34-00
4
2024-03-27
Neoplasm malignant
-
2023-504678-39-00
4
2024-03-13
Heart Failure
-
2023-507035-37-00
1
2024-03-11
Circulatory shock
-
2023-505499-32-00
5
2024-03-08
Uncontrolled hypertension (uTHN) defined as blood pressure that remain
-
2023-503315-15-00
4
2023-12-20
Thrombolysis of symptomatic proximal vein thrombosis
-
2023-505859-45-00
4
2023-12-19
Risk for renal damage following open heart surgery
-
2022-501418-69-00
5
2023-11-21
Acute Coronary Syndrome
-
2022-502339-20-00
4
2023-11-15
Squamous cell carcinoma of head and neck